Trends in Prescribed NSAID Usage
Prevalence trends of prescribed non-steroidal anti-inflammatory drug (NSAID) usage among adults with and without chronic kidney disease (CKD) stages revealed variations over the years, with a notable decrease after 2001-2004. Data from NHANES & Clinformatics Commercial highlight changes in NSAID prescriptions and usage among different CKD stages from 2001 to 2020.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Trends in Prescribed NSAID Usage Trends in Prescribed NSAID Usage Prevalence of adults reporting usage of prescribed non-steroidal anti-inflammatory drugs (NSAID) tended to be lower after 2001 2004. The use of any NSAID was 9.5% among adults with chronic kidney disease (CKD) stages 3 5, 6.0% in those with CKD stages 1 2, and 5.9% in those without CKD during 2017 March 2020. Compared with the crude prevalence, the age-standardized prevalence of NSAID use among adults with stage 3 5 changed greatly except for the 2009 2012 surveys. In contrast, the prevalence of NSAIDs prescriptions has increased slightly among the Clinformatics Commercially insured population. NSAIDs use was 19.6% among adults with diagnosed CKD stages 1 2, 15.0% among adults with CKD stages 3 5, and 12.6% among those with no diagnosis of CKD in 2020. Data Source: NHANES & Clinformatics Commercial https://nccd.cdc.gov/CKD/detail.aspx?Qnum=Q700
Crude Trends in Prescribed NSAID Usage in NHANES Crude Trends in Prescribed NSAID Usage in NHANES 18 16 14 NSAID use (%) 12 10 8 6 4 2 0 2001 2004 2005 2008 2009 2012 2013 2016 2017 2020 No CKD CKD Stages 1 2 CKD Stages 3 5 All Stages Combined
Age Age- -Standardized Trends in Prescribed NSAID Usage in NHANES Standardized Trends in Prescribed NSAID Usage in NHANES 18 16 14 NSAID use (%) 12 10 8 6 4 2 0 2001 2004 2005 2008 2009 2012 2013 2016 2017 2020 No CKD CKD Stages 1 2 CKD Stages 3 5 All Stages Combined
Crude Trends in Prescribed NSAID Usage in Crude Trends in Prescribed NSAID Usage in Clinformatics Clinformatics Commercial Commercial 20 NSAID use (%) 15 10 5 0 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 All Stages CKD Stage 1-2 CKD Stage 3-5 No-CKD
